SCHEMBL18934339

SCHEMBL18934339

C=C(C)CC(N)CCCCCCCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 6/20 0.47
S1PR1 P21453 6/20 0.47
S1PR3 Q99500 5/20 0.47
S1PR4 O95977 4/20 0.47
PLA2G1B P04054 1/20 0.47
PLA2G2A P14555 1/20 0.47
SPHK1 Q9NYA1 2/20 0.45
OPRM1 P35372 1/20 0.43
CYP2D6 P10635 2/20 0.42
LMNA P02545 2/20 0.42
GMNN O75496 1/20 0.42
POLB P06746 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42
BLM P54132 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18699305 1.00 S1PR2 (0.47) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL3691020 0.98 OPRM1 (0.44) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL24799699 0.83 ALDH1A1 (0.40) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL29130481 0.82 S1PR2 (0.50) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL9676602 0.81 GSR (0.39)
SCHEMBL28305103 0.79 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL1561204 0.79 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL13675239 0.79 S1PR2 (0.52) S1PR2S1PR1S1PR3S1PR4PLA2G1B
SCHEMBL25501505 0.77 GPR84 (0.59) PLA2G1BSPHK1LMNACYP3A4
SCHEMBL22806886 0.77 ACE2 (0.47) SPHK1OPRM1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3037405-B1 3-ACYLOXYMETHYL-3-BUTENYL CARBOXYLATE COMPOUND AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHINETSU CHEMICAL CO (JP) 2019-10-30 EP disclosed
US-20170158626-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHINETSU CHEMICAL CO (JP) 2017-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158626-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE MPST, ZDHHC7, MSMO1 S1PR2 1418/4885S1PR1 1788/4885S1PR3 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.